The possibility of increased VEGF-A and CCL2, in definite ALS due to respiratory dysfunction, may not be ruled out even though only 28% of all definite ALS cases presented with respiratory symptoms. The gene discussed is CCL2; the disease is amyotrophic lateral sclerosis.